Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 141, Issue , 2021, Pages 1-6

  Pastori, Daniele ^a,b   Biccirè, Flavio Giuseppe ^a   Lip, Gregory Yoke Hong ^b,c   Menichelli, Danilo ^a   Pignatelli, Pasquale ^a   Barillà, Francesco ^a   Violi, Francesco ^a   Gaudio, Carlo ^a   Tanzilli, Gaetano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTON PUMP INHIBITOR;

AGED; ARTERY OCCLUSION; ARTICLE; ATRIAL FIBRILLATION; CHA2DS2-VASC SCORE; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSEL MALFORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBTUSE MARGINAL ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ST ELEVATED MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 85097167935     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2020.11.006     Document Type: Article

References (22)

1. Odutayo, A, Wong, CX, Hsiao, AJ, Hopewell, S, Altman, DG, Emdin, CA, Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ, 354, 2016, i4482.
2. Soliman, EZ, Safford, MM, Muntner, P, Khodneva, Y, Dawood, FZ, Zakai, NA, Thacker, EL, Judd, S, Howard, VJ, Howard, G, Herrington, DM, Cushman, M, Atrial fibrillation and the risk of myocardial infarction. JAMA Int Med 174 (2014), 107–114.
3. Lip, GY, Lane, DA., Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients. Am J Med 123 (2010), 785–789.
4. Pastori, D, Pignatelli, P, Saliola, M, Carnevale, R, Vicario, T, Del Ben, M, Cangemi, R, Barilla, F, Lip, GY, Violi, F, Inadequate anticoagulation by Vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation. Int J Cardiol 201 (2015), 513–516.
5. Pokorney, SD, Piccini, JP, Stevens, SR, Patel, MR, Pieper, KS, Halperin, JL, Breithardt, G, Singer, DE, Hankey, GJ, Hacke, W, Becker, RC, Berkowitz, SD, Nessel, CC, Mahaffey, KW, Fox, KA, Califf, RM, Committee, RAS, Investigators, Investigators RASC. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF. J Am Heart Assoc, 5, 2016, e002197.
6. Fauchier, L, Villejoubert, O, Clementy, N, Bernard, A, Pierre, B, Angoulvant, D, Ivanes, F, Babuty, D, Lip, GY, Causes of death and influencing factors in patients with atrial fibrillation. Am J Med 129 (2016), 1278–1287.
7. Pastori, D, Farcomeni, A, Poli, D, Antonucci, E, Angelico, F, Del Ben, M, Cangemi, R, Tanzilli, G, Lip, GY, Pignatelli, P, Violi, F, Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. Intern Emerg Med 11 (2016), 199–204.
8. Tonino, PA, De Bruyne, B, Pijls, NH, Siebert, U, Ikeno, F, van' t Veer, M, Klauss, V, Manoharan, G, Engstrom, T, Oldroyd, KG, Ver Lee, PN, MacCarthy, PA, Fearon, WF, Investigators, FS, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360 (2009), 213–224.
9. Batra, G, Svennblad, B, Held, C, Jernberg, T, Johanson, P, Wallentin, L, Oldgren, J, All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart 102 (2016), 926–933.
10. Soliman, EZ, Lopez, F, O'Neal, WT, Chen, LY, Bengtson, L, Zhang, ZM, Loehr, L, Cushman, M, Alonso, A, Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study. Circulation 131 (2015), 1843–1850.
11. Violi, F, Soliman, EZ, Pignatelli, P, Pastori, D, Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc, 5, 2016, e003347.
12. Davies, JE, Sen, S, Dehbi, HM, Al-Lamee, R, Petraco, R, Nijjer, SS, Bhindi, R, Lehman, SJ, Walters, D, Sapontis, J, Janssens, L, Vrints, CJ, Khashaba, A, Laine, M, Van Belle, E, Krackhardt, F, Bojara, W, Going, O, Harle, T, Indolfi, C, Niccoli, G, Ribichini, F, Tanaka, N, Yokoi, H, Takashima, H, Kikuta, Y, Erglis, A, Vinhas, H, Canas Silva, P, Baptista, SB, Alghamdi, A, Hellig, F, Koo, BK, Nam, CW, Shin, ES, Doh, JH, Brugaletta, S, Alegria-Barrero, E, Meuwissen, M, Piek, JJ, van Royen, N, Sezer, M, Di Mario, C, Gerber, RT, Malik, IS, Sharp, ASP, Talwar, S, Tang, K, Samady, H, Altman, J, Seto, AH, Singh, J, Jeremias, A, Matsuo, H, Kharbanda, RK, Patel, MR, Serruys, P, Escaned, J, Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 376 (2017), 1824–1834.
13. Gotberg, M, Christiansen, EH, Gudmundsdottir, IJ, Sandhall, L, Danielewicz, M, Jakobsen, L, Olsson, SE, Ohagen, P, Olsson, H, Omerovic, E, Calais, F, Lindroos, P, Maeng, M, Todt, T, Venetsanos, D, James, SK, Karegren, A, Nilsson, M, Carlsson, J, Hauer, D, Jensen, J, Karlsson, AC, Panayi, G, Erlinge, D, Frobert, O, i FRSI. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 376 (2017), 1813–1823.
14. Kralev, S, Schneider, K, Lang, S, Suselbeck, T, Borggrefe, M, Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PloS one, 6, 2011, e24964.
15. Williams, MC, Moss, AJ, Dweck, M, Adamson, PD, Alam, S, Hunter, A, Shah, ASV, Pawade, T, Weir-McCall, JR, Roditi, G, van Beek, EJR, Newby, DE, Nicol, ED, Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol 73 (2019), 291–301.
16. Lee, CJ, Pallisgaard, JL, Olesen, JB, Carlson, N, Lamberts, M, Gislason, GH, Torp-Pedersen, C, Brandes, A, Husted, SE, Johnsen, SP, Hansen, ML, Antithrombotic therapy and first myocardial infarction in patients with atrial fibrillation. J Am Coll Cardiol 69 (2017), 2901–2909.
17. Mehta, LS, Beckie, TM, DeVon, HA, Grines, CL, Krumholz, HM, Johnson, MN, Lindley, KJ, Vaccarino, V, Wang, TY, Watson, KE, Wenger, NK, American Heart Association Cardiovascular Disease in W, Special Populations Committee of the Council on Clinical Cardiology CoE, Prevention CoC, Stroke N, Council on Quality of C, Outcomes R. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation 133 (2016), 916–947.
18. Bairey Merz, CN, Shaw, LJ, Reis, SE, Bittner, V, Kelsey, SF, Olson, M, Johnson, BD, Pepine, CJ, Mankad, S, Sharaf, BL, Rogers, WJ, Pohost, GM, Lerman, A, Quyyumi, AA, Sopko, G, Investigators, W, Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 47 (2006), S21–S29.
19. Johnston, N, Schenck-Gustafsson, K, Lagerqvist, B, Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain. Eur Heart J 32 (2011), 1331–1336.
20. Lip, GYH, Collet, JP, Haude, M, Byrne, R, Chung, EH, Fauchier, L, Halvorsen, S, Lau, D, Lopez-Cabanillas, N, Lettino, M, Marin, F, Obel, I, Rubboli, A, Storey, RF, Valgimigli, M, Huber, K, Group, ESCSD, 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace 21 (2019), 192–193.
21. Pastori, D, Menichelli, D, Del Sole, F, Pignatelli, P, Violi, F, group A-As. Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants. Mayo Clin Proc, 2020, 10.1016/j.mayocp.2020.06.057.
22. Lee, CJ, Gerds, TA, Carlson, N, Bonde, AN, Gislason, GH, Lamberts, M, Olesen, JB, Pallisgaard, JL, Hansen, ML, Torp-Pedersen, C, Risk of myocardial infarction in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 72 (2018), 17–26.